U.S. Home Infusion Therapy Market

U.S. Home Infusion Therapy Market is valued at USD 16.8 Billion in 2021 and expected to reach USD 21.65 Billion by 2028 with a CAGR of 3.68% over the forecast period.

U.S. Home Infusion Therapy Market: Size, Trends, Competitive, And Historical & Forecast Analysis, 2022-2029: Shift toward home healthcare, advancements in technology, and the rising prevalence of chronic diseases are some of the major factors driving the growth of the U.S. Home Infusion Therapy Market.

Scope-

Home infusion treatment predominantly involves the administration of   medications or biologicals intravenously or subcutaneously to a patient at home. The medicine (for example, immune globulin or antivirals), supplies, and equipment are all required for home infusion (for example, catheters and tubing). Nursing services are also required to teach and educate patients and their families on the proper administration of infusion medications at home.

Visiting nurses are often involved in home infusion. Nurses often teach the caregiver or patient to self-administer the medicine, educate on side effects and therapeutic objectives, and check the infusion site on a regular basis to monitor the infusion site and change the dressing. Patients, doctors, health insurance, hospital discharge planners, home infusion pharmacies, and, if available, home health organizations are often involved in the home infusion procedure.

Impact of COVID-19:

The COVID-19 outbreak had a beneficial influence on the US market. Due to the considerable rise in the number of individuals receiving infusion treatment at home under COVID-19 limitations, key businesses reported significant increases in their revenue from equipment, medications, and services. Furthermore, with the COVID-19 epidemic, home-infusion treatments became more vital than ever, letting patients stay at home and reducing the danger of exposure. As a result, different local infusion service providers saw a rise in demand for home-based services. For example, Arkansas-based Delta Medical Infusion reported 50% growth in their patient for home infusion treatment services as compared to the preceding year.

The COVID-19 pandemic resulted in an increase in hospitalization of a select group, with many being placed on ventilators. This took up room in clinics since the polluted patients needed to be sent somewhere where they wouldn't degrade patients or medical care specialists. Due to the increasing demand for beds and space in emergency clinics, companies are concentrating on transitioning patients from the clinic to in-home care, sparking attention in home infusion treatment.

Key Players:

The major players operating in this market sphere are -

• Baxter International Inc.
• B. Braun Melsungen AG
• Contec Medical Systems Co. Ltd
• Fresenius Kabi
• Terumo Corporation
• Becton Dickinson and Company
• Erenler Medikal
• ICU Medical Inc.
• Amsino International Inc.
• Moog Inc.
• Lepu Medical Technology
• JMS Co. Ltd.
• others

Segmentation:

By Product:

• Infusion Pumps
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

By Route of Administration:

• Intramuscular
• Subcutaneously
• Epidural

By Application:

• Endocrinology
• Anti-infective
• Chemotherapy
• Hydration Therapy
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Enteral Nutrition
• Others

By End-User:

• Patients
• Nurse
• Hospitals
• Others

Market Drivers:

Shift towards home healthcare:

Patient care is increasingly being given outside of hospital environments as healthcare improves. The aging population in the United States is driving this shift in healthcare delivery. For example, the United States Census Bureau predicts that by 2030, the percentage of U.S. inhabitants over the age of 65 would almost double in comparison to the elderly population in 2010 (20% vs 13%). Healthcare organizations all around the globe, including those located in the United States, are concentrating on shifting patients to homecare facilities in order to alleviate the load on healthcare settings in terms of costs as well as other resources.

This has resulted in many measures suggested and executed by regulatory bodies in the United States, such as raising awareness about home care, realigning payment rules for pharmaceuticals and equipment, and providing services to patients in homecare settings, among other things. Furthermore, due to less caregiver and patient exposure to a clinic or hospital environment, home infusion may lower the chance of getting a healthcare-associated infection.

There is a greater emphasis on lowering the occurrence of healthcare-associated infections (HAIs) in the nation, due to the high expenses involved with treating these diseases, which place an extra economic strain on the country's health service. As reported by the Centers for Disease Control and Prevention, HAIs cause approximately 1.7 million illnesses in the United States each year. Each year, these diseases cost the United States around USD 28 billion in acute medical expenditures, as well as USD 12 billion in hidden costs.

Technological Innovations:

The fast use of modern healthcare technology for enhanced health services is one of the primary drivers driving market competition. Furthermore, large firms often use methods such as acquisitions, mergers, and new product releases to retain market share and expand their product range.

Hillrom was acquired by Baxter International in December 2021. This purchase helps the firm expand its global presence and integrate medical device technologies, which will improve patient care, cut costs, and boost workflow efficiency. Smiths Medical and Ivenix, Inc. signed a collaboration agreement in May 2021 to deliver a full portfolio of infusion management services in the United States market. This collaboration is projected to increase patient safety through evolving infusion management.

Increased prevalence of Chronic illnesses :

The rising incidence of chronic and acute disorders in the United States, such as hemophilia, cancer, immunological deficiencies, autoimmune diseases, rheumatoid arthritis, multiple sclerosis, and others, as well as the move toward home healthcare settings for infusion treatment, are driving market expansion.

Chronic illnesses continue to have an influence on people's lives and increase the usage of drugs and other diagnostic tests. The number of individuals diagnosed with chronic diseases such as cancer, asthma, and chronic obstructive pulmonary disease, among many others, has increased throughout time. According to the Asthma and Allergy Foundation of America, about 20.4 million individuals in the United States will be diagnosed with asthma by 2021. Asthmatic individuals are turning to at-home infusion therapy to avoid airway irritation in order to save money on healthcare.

Diabetes is another chronic illness that kills a lot of people. Diabetes kills over 37 million individuals in the United States, as reported by the Centers for Disease Control and Prevention.

News:

Smiths Medical acquired by ICU Medical from Smiths Group plc

On January 6^th, 2022; ICU Medical Inc. announced the completion of its purchase of Smiths Medical from Smiths Group plc. Smiths Medical manufactures ambulatory infusion devices and syringe, as well as vascular access and critical care items. When united with ICU Medical's current operations, the combined firms establish a prominent infusion treatment corporation with roughly USD 2.5 billion in pro forma sales revenue.

CarepathRx Announced the Partnership with Mount Sinai Health System for Home Infusion

On April 27^th, 2022; CarepathRx, a leading provider of health system medication and pharmacy management solutions, announced a complete home infusion pharmacy relationship with Mount Sinai Health System  This multi-year partnership will increase patients ’ access to house infusion therapy throughout the Mount Sinai Health System's hospital units and ambulatory network.

Yale New Haven Health has started a home infusion service

On September 9^th, 2022; Yale New Haven Health started a home infusion program, which will increase access to treatment at home, improve patient conveniences, and reduce obstacles and interruptions in care. The Home Infusion Center is situated in the YNHHS Regional Operations Center and is the biggest of its type in Connecticut, measuring 8,475 square feet.

This investment would benefit all of our patients since medication therapy may be provided safely and with the same levels of care as in the healthcare setting.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2021:	USD 16.8 Billion
Base year considered	2021
Forecast Period CAGR %:	3.68%
Market Size Expected in 2028:	USD 21.65 Billion
Tables, Charts & Figures:	175
Pages	300
Companies	Baxter International Inc., B. Braun Melsungen AG, Contec Medical Systems Co. Ltd, Fresenius Kabi, Terumo Corporation, Becton Dickinson and Company, Erenler Medikal, ICU Medical Inc., Amsino International, Inc., Moog Inc., Lepu Medical Technology, JMS Co. Ltd., and others
Segments Covered	By Product, By Route of Administration, By End-User, By Application
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa